A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma. . . . → Read More: Hearing Loss Cell Therapy Licensed in $625M Deal
|
|||||
|
|
A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech. . . . → Read More: Genentech, Biotech Partner on Multiple Sclerosis 
A mobile and computer app that alerts older citizens about a class of drugs associated with Alzheimer’s disease will soon be tested in a clinical trial. . . . → Read More: Trial to Test App Alerting for Dementia-Linked Drugs 
First results from a clinical trial show a combination of immunotherapies extends survival among patients with melanoma, but shorter periods for other solid-tumor cancers. . . . → Read More: Trial Shows Immunotherapies Extend Life with Melanoma 
Researchers expanded the ability of the genetic editing technique known as Crispr to alter the make-up of RNA, adding more ways to treat diseases. . . . → Read More: Crispr Enhanced for RNA Editing 
Labs in the U.S. and the Netherlands developed techniques to sustainably produce high-quality graphene with more capabilities, using a strain of bacteria. . . . → Read More: Bacteria Recruited to Produce Graphene 
An analysis of drugs approved for use in Germany since 2011 shows no evidence most treatments provide new or added benefits to patients compared to standard care. . . . → Read More: Analysis – Most New Drugs Not Adding Patient Benefits 
A company developing diagnostics for cognitive disorders from changes in speech patterns is partnering on vocal biomarkers to track progression of a form of dementia. . . . → Read More: Voice Indicators to Monitor Dementia Progression 
A biotechnology enterprise developing personalized treatments for cancer and infectious diseases is raising $325 million in its second venture funding round. . . . → Read More: Immunotherapy Biotech Gains $325M in Venture Funds  Comments are closed  Finance  biomedical, biotechnology, cancer, equity, Europe, genomics, investment, licensing, life sciences, manufacturing, pharmaceuticals, university, venture capital 
A contract research organization, or CRO, specializing in clinical trials is adding blockchain capability for data management, with help from an engineering consulting firm. . . . → Read More: Blockchain Added to Clinical Trials Management Comments are closed Joint ventures/collaborations biomedical, blockchain, clinical trials, computer science, engineering, life sciences, physical sciences, software |
||||
|
Copyright © 2019 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||